SCHEMBL14898280

SCHEMBL14898280

C=CCN(CC=C)c1cccc(C(=O)OCC)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ALDH1A1 P00352 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
MAPK1 P28482 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PTPN1 P18031 2/20 0.47
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
GAA P10253 3/20 0.46
ALOX5 P09917 1/20 0.46
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876996 0.88 LMNA (0.48) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL1574716 0.84 CYP4F2 (0.52) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL1470467 0.82 CA12 (0.53) LMNAMAPTALDH1A1NPC1RAB9A
SCHEMBL32685467 0.82 MAPT (0.65) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL3236449 0.82 MAPT (0.65) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL15127569 0.81 CYP4F2 (0.54) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL14879820 0.81 CYP4F2 (0.50) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL6154529 0.80 PTPN1 (0.42) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL4872329 0.80 LMNA (0.41) LMNAMAPTNPSR1ALDH1A1NPC1
SCHEMBL876064 0.79 PTPN1 (0.49) LMNAALDH1A1PTPN1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME UNIV CORNELL (US) 2020-11-12 US disclosed
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2014-07-10 US disclosed
WO-2013058824-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 LMNA 1549/4885MAPT 1617/4885NPSR1 2912/4885
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 LMNA 1549/4885MAPT 1617/4885NPSR1 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.